Anonymous: "PD-L1/CD274 Monoclonal ANTIBODY", , 27 September 2017 (2017-09-27), pages 1-2, XP055410791, Retrieved from the Internet: URL:https://www.ptglab.com/Products/Pictur es/pdf/66248-1-Ig.pdf [retrieved on 2017-09-27] (B1)

WO-A2-2008/083174 (B1)

DONG HAIDONG ET AL: "Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion", NATURE MEDICINE, NATURE PUBLISHING GROUP, NEW YORK, NY, US, vol. 8, no. 8, 24 June 2002 (2002-06-24), pages 793-800, XP002397368, ISSN: 1078-8956 (B1)

EP-A1- 1 537 878 (B1)

FÉRAUDET C ET AL: "Screening of 145 anti-PrP monoclonal antibodies for their capacity to inhibit PrPSc replication in infected cells", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY, US, vol. 280, no. 12, 25 March 2005 (2005-03-25), pages 11247-11258, XP002590033, ISSN: 0021-9258, DOI: 10.1074/JBC.M407006200 [retrieved on 2004-12-23] (B1)

HOLT L J ET AL: "Domain antibodies: proteins for therapy", TRENDS IN BIOTECHNOLOGY, ELSEVIER PUBLICATIONS, CAMBRIDGE, GB, vol. 21, no. 11, 1 November 2003 (2003-11-01), pages 484-490, XP004467495, ISSN: 0167-7799, DOI: 10.1016/J.TIBTECH.2003.08.007 (B1)

IWAI YOSHIKO ET AL: "Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, NATIONAL ACADEMY OF SCIENCES, US, vol. 99, no. 19, 17 September 2002 (2002-09-17), pages 12293-12297, XP002398159, ISSN: 0027-8424, DOI: 10.1073/PNAS.192461099 (B1)

L. ZHANG ET AL: "PD-1/PD-L1 interactions inhibit antitumor immune responses in a murine acute myeloid leukemia model", BLOOD, vol. 114, no. 8, 20 August 2009 (2009-08-20), pages 1545-1552, XP055053821, ISSN: 0006-4971, DOI: 10.1182/blood-2009-03-206672 (B1)

M. V. GOLDBERG ET AL: "Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells", BLOOD, vol. 110, no. 1, 1 July 2007 (2007-07-01), pages 186-192, XP055053809, ISSN: 0006-4971, DOI: 10.1182/blood-2006-12-062422 (B1)

NOMI TAKEO ET AL: "Clinical significance and therapeutic potential of the programmed death-1 ligand/programmed death-1 pathway in human pancreatic cancer", CLINICAL CANCER RESEARCH, THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, US, vol. 13, no. 7, 1 April 2007 (2007-04-01), pages 2151-2157, XP002533527, ISSN: 1078-0432, DOI: 10.1158/1078-0432.CCR-06-2746 (B1)

Nareen Abboud ET AL: "Identification of Linear Epitopes in Bacillus anthracis Protective Antigen Bound by Neutralizing Antibodies", Journal of Biological Chemistry, vol. 284, no. 37, 11 September 2009 (2009-09-11), pages 25077-25086, XP055411252, US ISSN: 0021-9258, DOI: 10.1074/jbc.M109.022061 (B1)

OKUDAIRA: "Blockade of B7-H1 or B7-DC induces an anti-tumor effect in a mouse pancreatic cancer model", INTERNATIONAL JOURNAL OF ONCOLOGY, vol. 35, no. 4, 1 September 2009 (2009-09-01), XP055052567, ISSN: 1019-6439, DOI: 10.3892/ijo_00000387 (B1)

SOPHIE R. SIERRO ET AL: "Combination of lentivector immunization and low-dose chemotherapy or PD-1/PD-L1 blocking primes self-reactive T cells and induces anti-tumor immunity", EUROPEAN JOURNAL OF IMMUNOLOGY, vol. 41, no. 8, 1 August 2011 (2011-08-01) , pages 2217-2228, XP055053701, ISSN: 0014-2980, DOI: 10.1002/eji.201041235 (B1)

WERTHER W A ET AL: "HUMANIZATION OF AN ANTI-LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN (LFA)-1 MONOCLONAL ANTIBODY AND REENGINEERING OF THE HUMANIZED ANTIBODY FOR BINDING TO RHESUS LFA-1", THE JOURNAL OF IMMUNOLOGY, THE AMERICAN ASSOCIATION OF IMMUNOLOGISTS, US, vol. 157, no. 11, 1 December 1996 (1996-12-01), pages 4986-4995, XP002054057, ISSN: 0022-1767 (B1)

WO-A1-2010/077634 (B1)

WO-A2-2007/005874 (B1)

BLANK CHRISTIAN ET AL: "Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responses in vitro", INTERNATIONAL JOURNAL OF CANCER, JOHN WILEY & SONS, INC, NEW YORK, NY; US, vol. 119, no. 2, 1 July 2006 (2006-07-01), pages 317-327, XP002557386, ISSN: 0020-7136, DOI: 10.1002/IJC.21775 (B1)